RV-6153

N/A

Report date: 2022/07/19 16:22:54
NME

Base Information

Drug NameRV-6153
Drug Alias NameRV-6153
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPI3-kinase class I modulators
TargetsPI3-kinase class I
Therapy Area/IndicationsAsthma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesRespivert Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRespivert Ltd
Active IndicationsN/A
Inactive IndicationsAsthma

Other Information

ATC CodeN/A
Related LinksN/A